Cargando…

(18)F-FDG PET/CT versus Diagnostic Contrast-Enhanced CT for Follow-Up of Stage IV Melanoma Patients Treated by Immune Checkpoint Inhibitors: Frequency and Management of Discordances over a 3-Year Period in a University Hospital

Aim: To perform a comprehensive analysis of discordances between contrast-enhanced CT (ceCT) and (18)F-FDG PET/CT in the evaluation of the extra-cerebral treatment monitoring in patients with stage IV melanoma. Materials and methods: We conducted a retrospective monocentric observational study over...

Descripción completa

Detalles Bibliográficos
Autores principales:	Le Goubey, Jean-Baptiste, Lasnon, Charline, Nakouri, Ines, Césaire, Laure, de Pontville, Michel, Nganoa, Catherine, Kottler, Diane, Aide, Nicolas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8304093/ https://www.ncbi.nlm.nih.gov/pubmed/34359281 http://dx.doi.org/10.3390/diagnostics11071198

Ejemplares similares

Comprehensive analysis of the influence of G-CSF on the biodistribution of (18)F-FDG in lymphoma patients: insights for PET/CT scheduling
por: Oliveira, Magno, et al.
Publicado: (2019)

Diagnostic and prognostic value of baseline FDG PET/CT skeletal textural features in diffuse large B cell lymphoma
por: Aide, Nicolas, et al.
Publicado: (2017)

Diagnostic value of baseline (18)FDG PET/CT skeletal textural features in follicular lymphoma
por: Faudemer, Julie, et al.
Publicado: (2021)

Assessment of alteration in liver (18)F–FDG uptake due to steatosis in lymphoma patients and its impact on the Deauville score
por: Salomon, Thibault, et al.
Publicado: (2017)

HYPHYCA: a prospective study in 613 patients conducting a comprehensive analysis for predictive factors of physiological (18)F-FDG anal uptake
por: Aide, Nicolas, et al.
Publicado: (2020)

Prediction of the Presence of Targetable Molecular Alteration(s) with Clinico-Metabolic (18) F-FDG PET Radiomics in Non-Asian Lung Adenocarcinoma Patients
por: Aide, Nicolas, et al.
Publicado: (2022)

Contrast-enhanced small-animal PET/CT in cancer research: strong improvement of diagnostic accuracy without significant alteration of quantitative accuracy and NEMA NU 4–2008 image quality parameters
por: Lasnon, Charline, et al.
Publicado: (2013)

PET/CT variants and pitfalls in malignant melanoma
por: Aide, Nicolas, et al.
Publicado: (2022)

Deep Learning Denoising Improves and Homogenizes Patient [(18)F]FDG PET Image Quality in Digital PET/CT
por: Weyts, Kathleen, et al.
Publicado: (2023)

Implications of reconstruction protocol for histo-biological characterisation of breast cancers using FDG-PET radiomics
por: Aide, Nicolas, et al.
Publicado: (2018)

Artificial intelligence-based PET denoising could allow a two-fold reduction in [(18)F]FDG PET acquisition time in digital PET/CT
por: Weyts, Kathleen, et al.
Publicado: (2022)

PET imaging and quantification of small animals using a clinical SiPM-based camera
por: Desmonts, Cédric, et al.
Publicado: (2023)

Hormonal Receptor Immunochemistry Heterogeneity and (18)F-FDG Metabolic Heterogeneity: Preliminary Results of Their Relationship and Prognostic Value in Luminal Non-Metastatic Breast Cancers
por: Aide, Nicolas, et al.
Publicado: (2021)

FDG-PET/CT in lymphoma
por: D'souza, Maria M, et al.
Publicado: (2013)

Discordant Metabolic Response on (18)F-FDG PET/CT in Synchronous Primary Gastric Lymphoma and Gastric Adenocarcinoma
por: Hao, Wanting, et al.
Publicado: (2022)

Pretherapeutic Assessment of Pancreatic Cancer: Comparison of FDG PET/CT Plus Delayed PET/MR and Contrast-Enhanced CT/MR
por: Zhang, Zaizhu, et al.
Publicado: (2022)

Detecting the Recurrence of Gastric Cancer after Curative Resection: Comparison of FDG PET/CT and Contrast-Enhanced Abdominal CT
por: Kim, Dae-Weung, et al.
Publicado: (2011)

Detection of Primary Malignancy and Metastases with FDG PET/CT in Patients with Cholangiocarcinomas: Lesion-based Comparison with Contrast Enhanced CT
por: Elias, Youssef, et al.
Publicado: (2016)

F-18 FDG PET-CT Versus Contrast Enhanced CT in Detection of Extra Nodal Involvement in Patients with Lymphoma
por: Alnouby, Aboelmagd, et al.
Publicado: (2018)

Clinical utility of FDG-PET/CT for post-surgery surveillance of malignant pleural mesothelioma – Comparison with contrast-enhanced CT
por: Kitajima, Kazuhiro, et al.
Publicado: (2019)

FDG-PET/CT Versus Contrast-Enhanced CT for Response Evaluation in Metastatic Breast Cancer: A Systematic Review
por: Helland, Fredrik, et al.
Publicado: (2019)

Quantifying and correcting for tail vein extravasation in small animal PET scans in cancer research: is there an impact on therapy assessment?
por: Lasnon, Charline, et al.
Publicado: (2015)

FDG-Avid Portal Vein Tumor Thrombosis from Hepatocellular Carcinoma in Contrast-Enhanced FDG PET/CT
por: Nguyen, Xuan Canh, et al.
Publicado: (2015)

FDG PET/CT of COVID-19
por: Zou, Sijuan, et al.
Publicado: (2020)

FDG-PET and PET/CT - Part II
por: Takalkar, Amol M, et al.
Publicado: (2008)

Prediction of Early Response to Immune Checkpoint Inhibition Using FDG-PET/CT in Melanoma Patients
por: Kudura, Ken, et al.
Publicado: (2021)

Imaging Features of Multiple Myeloma Extramedullary Lesions in the Liver with 18F-FDG PET/CT, Contrast-Enhanced CT and MRI
por: Papamichail, Dimitris, et al.
Publicado: (2019)

Impact of the EARL harmonization program on automatic delineation of metabolic active tumour volumes (MATVs)
por: Lasnon, Charline, et al.
Publicado: (2017)

EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies
por: Aide, Nicolas, et al.
Publicado: (2017)

Initial Staging of Hodgkin’s Disease: Role of Contrast-Enhanced (18)F FDG PET/CT
por: Chiaravalloti, Agostino, et al.
Publicado: (2014)

Evaluation of a cardiac sarcoma with CT multislice contrast-enhanced and 18FDG-PET/TC
por: Guazzaroni, Manlio, et al.
Publicado: (2018)

FDG PET or PET/CT in Evaluation of Renal Angiomyolipoma
por: Lin, Chun-Yi, et al.
Publicado: (2013)

Detection of Metastatic Disease in Cardiophrenic Lymph Nodes: FDG PET/CT Versus Contrast-Enhanced CT and Implications for Staging and Treatment of Disease
por: Farmakis, Shannon, et al.
Publicado: (2013)

Preoperative Lymph Node Staging by FDG PET/CT With Contrast Enhancement for Thyroid Cancer: A Multicenter Study and Comparison With Neck CT
por: Chong, Ari, et al.
Publicado: (2017)

The role of FDG-PET/CT in gynaecological cancers
por: Rockall, Andrea G, et al.
Publicado: (2012)

Lymphomatoid Granulomatosis: CT and FDG-PET Findings
por: Chung, Jonathan H., et al.
Publicado: (2011)

FDG PET/CT in carcinoma of unknown primary
por: Kwee, Thomas C., et al.
Publicado: (2009)

Application of FDG-PET/CT in Radiation Oncology
por: Li, Jun, et al.
Publicado: (2013)

The Importance of FDG-PET/CT in Cogan’s Syndrome
por: Örsal, Ebru, et al.
Publicado: (2014)

Appropriateness criteria of FDG PET/CT in oncology
por: Agrawal, Archi, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_q1a5eleh129a8nphmjug48rbic